These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6142671

  • 21. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 22. Successful desensitization for azathioprine skin rash in a patient with severe Crohn's disease.
    Lavaud F, Abdelli N, Thiefin G.
    Dig Dis Sci; 1997 Apr; 42(4):823. PubMed ID: 9125656
    [No Abstract] [Full Text] [Related]

  • 23. [Desensitization to salicylazosulfapyridine (Salazopyrin) in a patient with ulcerative colitis].
    Chiba M, Murata M, Ihzuka M, Ohta H, Arakawa H, Masamune O, Ohkubo M.
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jan; 83(1):113-6. PubMed ID: 2871206
    [No Abstract] [Full Text] [Related]

  • 24. Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study.
    Lee B, Yu HJ, Kang ES, Lee M, Lee J.
    Pediatr Neurol; 2014 Aug; 51(2):207-14. PubMed ID: 25079569
    [Abstract] [Full Text] [Related]

  • 25. Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age.
    Clarke DF, George D, Milsap RL, Pogonowska-Wala E, Owerbach J, Lebenthal E, Jusko WJ.
    Pediatr Pharmacol (New York); 1982 Aug; 2(4):323-33. PubMed ID: 6152489
    [Abstract] [Full Text] [Related]

  • 26. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
    Das KM, Eastwood MA.
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531
    [Abstract] [Full Text] [Related]

  • 27. Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes.
    Mihas AA, Goldenberg DJ, Slaughter RL.
    JAMA; 1978 Jun 16; 239(24):2590-1. PubMed ID: 26816
    [No Abstract] [Full Text] [Related]

  • 28. Sulfasalazine-induced agranulocytosis.
    Jacobson IM, Kelsey PB, Blyden GT, Demirjian ZN, Isselbacher KJ.
    Am J Gastroenterol; 1985 Feb 16; 80(2):118-21. PubMed ID: 2857524
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C, Coughlan R.
    Ir J Med Sci; 1994 May 16; 163(5):238-9. PubMed ID: 7913919
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sulphasalazine: a review of 40 years' experience.
    Watkinson G.
    Drugs; 1986 May 16; 32 Suppl 1():1-11. PubMed ID: 2877847
    [Abstract] [Full Text] [Related]

  • 39. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA, van Tongeren JH.
    Ned Tijdschr Geneeskd; 1982 Oct 30; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.